Doxofylline 400 mg + Ambroxol 30 mg Tablet | PCD Pharma Manufacturer & Supplier India | Trumac Healthcare
Doxofylline 400 mg + Ambroxol 30 mg Tablet
WHO-GMP Manufacturer & PCD Pharma Franchise Supplier in India
Form: Tablet
Class: Bronchodilator + Mucolytic
✓ Pan-India Monopoly PCD
✓ 1 Brand Options
Pricing, brochure & monopoly territory within 24 hrs.
Our Doxofylline 400 mg + Ambroxol 30 mg Tablet Brand Options (1 option)
Trumac Healthcare manufactures and supplies the following Doxofylline 400 mg + Ambroxol 30 mg Tablet brands for PCD pharma distribution. Click any brand to view full specifications and packaging.
Doxofylline 400 mg + Ambroxol 30 mg Tablet is manufactured under WHO-GMP-certified conditions by Trumac Healthcare and supplied for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across India. Whether you are a PCD distributor, stockist or retail chemist, our Doxofylline 400 mg + Ambroxol 30 mg formulation comes with full quality assurance, regulatory documentation and reliable pan-India despatch.
Therapeutic Indications
- Productive bronchospasm
- COPD with mucus
- Chronic bronchitis
- Asthma with mucus plugging
Mechanism of Action
Doxofylline bronchodilates via PDE inhibition. Ambroxol breaks disulphide bonds in mucoprotein fibres, reducing mucus viscosity.
Dosage & Administration
- Adults: 1 tablet twice daily.
Side Effects
- Mild GI upset, headache.
Contraindications
- Hypersensitivity.
- Acute MI.
- Severe arrhythmias.
Storage
Store below 30 °C in a dry place, protected from light and moisture.
PCD Pharma Franchise for Doxofylline 400 mg + Ambroxol 30 mg Tablet
- ✓ WHO-GMP certified manufacturing facility
- ✓ Pan-India monopoly distribution rights available
- ✓ Multiple pack sizes: 10 x 10 (Blister)
- ✓ Trade-friendly PTR / PTS margins
- ✓ Free promotional material on request
- ✓ Full DCGI documentation and quality certificates supplied
Trumac Healthcare offers 1 brand option for Doxofylline 400 mg + Ambroxol 30 mg Tablet — each available in different pack sizes with trade-friendly margins. View the brand-specific pages below for detailed specifications, MRPs and packaging options.
For PCD franchise opportunities, monopoly distribution rights, or third-party contract manufacturing of Doxofylline 400 mg + Ambroxol 30 mg Tablet, contact our business development team. WhatsApp +91 9041677932 or email info@trumachealthcare.net.
Frequently Asked Questions
Who is the manufacturer of Doxofylline 400 mg + Ambroxol 30 mg Tablet?
Trumac Healthcare is a WHO-GMP certified manufacturer of Doxofylline 400 mg + Ambroxol 30 mg Tablet in India. We supply our own brand range (see brand options above) and also offer third-party contract manufacturing for PCD distributors.
Is Doxofylline 400 mg + Ambroxol 30 mg Tablet available for PCD pharma franchise on monopoly basis?
Yes. We offer Doxofylline 400 mg + Ambroxol 30 mg Tablet for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across all districts of India. Contact our business development team for pricing and territory availability.
What pack sizes are available for Doxofylline 400 mg + Ambroxol 30 mg Tablet?
Available pack sizes include: 10 x 10 (Blister).
What is the MRP / trade price for Doxofylline 400 mg + Ambroxol 30 mg Tablet?
MRPs range from ₹1320 to ₹1320 across our brand variants. Trade-friendly PTR/PTS margins available on request — WhatsApp +91 9041677932 for current rates.
How do I place an order or franchise enquiry?
WhatsApp +91 9041677932 or email info@trumachealthcare.net with your enquiry. Our team will revert within 24 hours with full pricing, brochure and franchise terms.
Ready to start your PCD franchise for Doxofylline 400 mg + Ambroxol 30 mg Tablet?